Tin tức & Cập nhật
Xem bài viết Nhãn khoa
Xem
Chỉ hiển thị Multimedia

Continued anti-VEGF use after disease control does not prevent nAMD recurrence
06 Apr 2022
In patients with neovascular age-related macular degeneration (nAMD) who achieve functional and morphological disease stability, continuing treatment with antivascular endothelial growth factors (anti-VEGF) does not substantially reduce the risk of recurrence, reports a recent study.
06 Apr 2022







